Clinical Performance of Existing Wearers of Enfilcon A Following a Refit With Fanfilcon A Lenses for 4 Weeks
1 other identifier
interventional
35
1 country
1
Brief Summary
The aim of this dispensing study is to evaluate the clinical performance of habitual wearers of enfilcon A lenses following a refit with fanfilcon A lenses over 4 weeks of daily wear.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2016
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2016
CompletedFirst Submitted
Initial submission to the registry
January 28, 2016
CompletedFirst Posted
Study publicly available on registry
February 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2016
CompletedResults Posted
Study results publicly available
March 21, 2017
CompletedFebruary 5, 2018
July 1, 2017
2 months
January 28, 2016
January 30, 2017
July 18, 2017
Conditions
Outcome Measures
Primary Outcomes (4)
Lens Fit - Centration
Lens fit evaluation of centration for enfilcon A habitual lens (control) is assessed at baseline and fanfilcon A lens (test) is assessed at 1 week, 2 weeks, and 4 weeks. Scale: optimum, decentration acceptable, decentration unacceptable.
Baseline, 1 week, 2 weeks, and 4 weeks
Lens Fit - Post-blink Movement
Lens fit evaluation of post-blink movement for enfilcon A habitual lens (control) is assessed at baseline and fanfilcon A lens (test) is assessed at 1 week, 2 weeks, and 4 weeks. Scale 0-5 Likert scale, 0=Insufficient, unacceptable movement, 1=Minimal, but acceptable movement, 2=Optimal movement, 3=Moderate, but acceptable movement, 4=Excessive, unacceptable movement.
Baseline, 1 week, 2 weeks, and 4 weeks
Lens Tightness on Push-up
Lens fit evaluation of tightness on push-up test for enfilcon A habitual lens (control) is assessed at baseline and fanfilcon A lens (test) is assessed at 1 week, 2 weeks, and 4 weeks. Scale: 0%-100%, 0%=Falls from cornea without lid support, 50%=Optimum, 100%=No movement.
Baseline, 1 week, 2 weeks, and 4 weeks
Overall Fit Acceptance
Overall fit acceptance for enfilcon A habitual lens (control) is assessed at baseline and fanfilcon A lens (test) is assessed at 1 week, 2 weeks, and 4 weeks. Scale 0-4, 0=Should not be worn, 1=Borderline but unacceptable, 2=Minimum acceptable, early review, 3=Not perfect but okay to dispense, 4=Perfect.
Baseline, 1 week, 2 weeks, and 4 weeks
Secondary Outcomes (9)
Overall Comfort
Baseline, 1 week, 2 weeks, and 4 weeks
Dryness Overall
Baseline, 1 week, 2 weeks, and 4 weeks
Handling
Baseline, 1 week, 2 weeks, and 4 weeks
Overall Vision Satisfaction
Baseline, 1 week, 2 weeks, and 4 weeks
Overall Satisfaction
Baseline, 1 week, 2 weeks, and 4 weeks
- +4 more secondary outcomes
Study Arms (2)
enfilcon A (habitual)
NO INTERVENTIONParticipants are habitual wearers of enfilcon A lens and refitted with fanfilcon A lens.
fanfilcon A (test)
EXPERIMENTALParticipants are habitual wearers of enfilcon A lens and refitted with fanfilcon A lens.
Interventions
Eligibility Criteria
You may qualify if:
- Is between 18 and 40 years of age
- Has had a self-reported visual exam in the last two years
- Is an adapted enfilcon A contact lens wearer (at least 2 weeks in enfilcon A lens)
- Has a contact lens spherical prescription between -1.00 to - 6.00
- Has a spectacle cylinder up to 0.75D (Diopters) in each eye.
- Can achieve best corrected spectacle distance visual acuity of 20/25 (0.10 logMAR) or better in each eye.
- Can achieve a distance visual acuity of 20/30 (0.18 logMAR) or better in each eye with the study contact lenses.
- Has clear corneas and no active ocular disease
- Has read, understood, and signed the information consent letter.
- Patient contact lens refraction should fit within the available parameters of the study lenses.
- Is willing to comply with the wear schedule (at least 5 days per week, \> 8 hours/day assuming there are no contraindications for doing so).
- Is willing to comply with the visit schedule
You may not qualify if:
- A person will be excluded from the study if he/she:
- Is not a habitual wearer of enfilcon A lenses
- Has a CL (Contact Lens) prescription outside the range of the available parameters of the study lenses.
- Has a spectacle cylinder ≥1.00D of cylinder in either eye.
- Has a history of not achieving comfortable CL wear (5 days per week; \> 8 hours/day)
- Has contact lens best corrected distance vision worse than 20/25 (0.10 logMAR) in either eye.
- Presence of clinically significant (grade 3-4) anterior segment abnormalities
- Presence of ocular or systemic disease or need of medications which might interfere with contact lens wear.
- Slit lamp findings that would contraindicate contact lens wear such as:
- Pathological dry eye or associated findings
- Pterygium, pinguecula, or corneal scars within the visual axis
- Neovascularization \> 0.75 mm in from of the limbus
- Giant papillary conjunctivitis (GCP) worse than grade 1
- Anterior uveitis or iritis (past or present)
- Seborrheic eczema, Seborrheic conjunctivitis
- +7 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Optometry Research Group (GIO) Optics Department, University of Valencia
Valencia, 46100, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Senior Manager Global Medical Scientific Affairs
- Organization
- CooperVision Inc.
Study Officials
- PRINCIPAL INVESTIGATOR
Robert Montés-Mico, O.D., PhD
Optometry Research Group (GIO) University of Valencia
Publication Agreements
- PI is Sponsor Employee
- No
- Restriction Type
- OTHER
- Restrictive Agreement
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 28, 2016
First Posted
February 1, 2016
Study Start
January 1, 2016
Primary Completion
March 1, 2016
Study Completion
May 1, 2016
Last Updated
February 5, 2018
Results First Posted
March 21, 2017
Record last verified: 2017-07